Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 P-glycoprotein (P-gp) and multidrug resistance-associated protein 1 (MRP1) are induced by arsenic trioxide (As(2)O(3)), but are not the main mechanism of As(2)O(3)-resistance in acute promyelocytic leukemia cells.

× No keyword cloud information.

5 in total

1. Establishment of an arsenic trioxide-resistant human leukemia cell line that shows multidrug resistance.

Authors: Tamami Seo; Yoshimasa Urasaki; Takanori Ueda
Journal: Int J Hematol Date: 2007-01 Impact factor: 2.490

2. Two patients with all-trans retinoic acid-resistant acute promyelocytic leukemia treated successfully with gemtuzumab ozogamicin as a single agent.

Authors: Akihiro Takeshita; Kaori Shinjo; Kensuke Naito; Hirotaka Matsui; Naohi Sahara; Kazuyuki Shigeno; Taeko Suzumura; Toshinobu Horii; Naohito Shirai; Masato Maekawa; Yoshihiro Yada; Hirofumi Teshima; Jin Takeuchi; Kazunori Ohnishi; Ryuzo Ohno
Journal: Int J Hematol Date: 2005-12 Impact factor: 2.490

3. Factors determining sensitivity and resistance of tumor cells to arsenic trioxide.

Authors: Serkan Sertel; Margaret Tome; Margaret M Briehl; Judith Bauer; Kai Hock; Peter K Plinkert; Thomas Efferth
Journal: PLoS One Date: 2012-05-10 Impact factor: 3.240

4. Elevation of cellular BPDE uptake by human cells: a possible factor contributing to co-carcinogenicity by arsenite.

Authors: Shengwen Shen; Jane Lee; Xuejun Sun; Hailin Wang; Michael Weinfeld; X Chris Le
Journal: Environ Health Perspect Date: 2006-12 Impact factor: 9.031

Review 5. Acute Promyelocytic Leukemia: Update on the Mechanisms of Leukemogenesis, Resistance and on Innovative Treatment Strategies.

Authors: N I Noguera; G Catalano; C Banella; M Divona; I Faraoni; T Ottone; W Arcese; M T Voso
Journal: Cancers (Basel) Date: 2019-10-18 Impact factor: 6.639

5 in total